Venture Life Group (LON:VLG) Insider Daniel Wells Purchases 14,760 Shares of Stock

Venture Life Group plc (LON:VLG – Get Free Report) insider Daniel Wells bought 14,760 shares of the company’s stock in a transaction on Thursday, October 1st. The stock was bought at an average price of GBX 68 per share, for a total transaction of £10,036.80.

Daniel Wells also recently made the following trade(s):

Get Venture Life Group alerts:

• On Wednesday, September 30th, Daniel Wells purchased 38,717 shares of Venture Life Group stock. The shares were bought at an average price of GBX 65 per share, with a total value of £25,166.05.

Venture Life Group Stock Performance

Shares of LON:VLG traded up GBX 3.50 during mid-day trading on Thursday, reaching GBX 69. The company had a trading volume of 1,029,339 shares, compared to its average volume of 276,889. The company’s 50-day moving average price is GBX 67.41 and its 200-day moving average price is GBX 65.09. Venture Life Group plc has a one year low of GBX 52 and a one year high of GBX 72. The firm has a market cap of £82.83 million, a price-to-earnings ratio of 15.79, a PEG ratio of 5.67 and a beta of 0.23. The company has a current ratio of 4.71, a quick ratio of 1.48 and a debt-to-equity ratio of 0.82.

Venture Life Group (LON:VLG – Get Free Report) last issued its earnings results on Tuesday, September 29th. The company reported GBX 4.10 earnings per share (EPS) for the quarter. Venture Life Group had a return on equity of 7.82% and a net margin of 17.42%. As a group, equities research analysts anticipate that Venture Life Group plc will post 6.1391542 EPS for the current fiscal year.

Venture Life Group Company Profile

(Get Free Report)

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.

Further Reading

• Five stocks we like better than Venture Life Group
• First Watch’s Growth Story Meets a Reality Check
• Down 50% and Climbing Again: 3 AI Stocks Rebuilding After Brutal Pullbacks
• Micron’s Earnings Reveal Why the AI Memory Boom May Last Longer
• Hobby Boom or Travel Bust? Here Are 3 Stocks to Ride the Trend

Receive News & Ratings for Venture Life Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venture Life Group and related companies with MarketBeat.com's FREE daily email newsletter.